Cardioprotective effect of resveratrol and resveratroloside Full article
Journal |
Cardiovascular and Hematological Agents in Medicinal Chemistry
ISSN: 1871-5257 |
||||
---|---|---|---|---|---|
Output data | Year: 2013, Volume: 11, Number: 3, Pages: 207-210 Pages count : DOI: 10.2174/187152571103140120103302 | ||||
Tags | Cardiovascular disease; In vivo experiments; Ischemia-reperfusion; Myocardial infarction; Myocardial ischemia; Natural stilbenes; Pinus sibirica; Preconditioning; Resveratrol; Resveratroloside | ||||
Authors |
|
||||
Affiliations |
|
Abstract:
Cardioprotective effect of resveratrol and resveratroloside was determined in ischemia-reperfusion experiments on rats. It was found that single intraperitoneal administration of any compound (10 mg/kg) followed by 30-min ischemia and 120-min reperfusion resulted in statistically significant decrease of myocardial infarct area (55.0±4.0% for control group; 40.7±4.4% for the group 1 received resveratrol; 41.6±4.8% for the group 2 received resveratroloside). The cardioprotective effect of resveratroloside was detected for the first time. © 2013 Bentham Science Publishers.
Cite:
Naumenko S.E.
, Latysheva T.V.
, Gilinsky M.A.
, Rogachev A.D.
, Komarova N.I.
, Salakhutdinov N.F.
, Tolstikov G.A.
Cardioprotective effect of resveratrol and resveratroloside
Cardiovascular and Hematological Agents in Medicinal Chemistry. 2013. V.11. N3. P.207-210. DOI: 10.2174/187152571103140120103302 Scopus РИНЦ
Cardioprotective effect of resveratrol and resveratroloside
Cardiovascular and Hematological Agents in Medicinal Chemistry. 2013. V.11. N3. P.207-210. DOI: 10.2174/187152571103140120103302 Scopus РИНЦ
Dates:
Published print: | Jan 31, 2014 |
Identifiers:
Scopus | 2-s2.0-84892963364 |
Elibrary | 21909451 |
OpenAlex | W2111792782 |